Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 309

1.

Human iPSC-Derived Neural Crest Stem Cells Exhibit Low Immunogenicity.

Mehler VJ, Burns CJ, Stauss H, Francis RJ, Moore ML.

Mol Ther Methods Clin Dev. 2020 Jan 13;16:161-171. doi: 10.1016/j.omtm.2019.12.015. eCollection 2020 Mar 13.

2.
3.

Segmental body composition evaluation by bioelectrical impedance analysis and dual-energy X-ray absorptiometry: Quantifying agreement between methods.

Moore ML, Benavides ML, Dellinger JR, Adamson BT, Tinsley GM.

Clin Nutr. 2019 Dec 13. pii: S0261-5614(19)33178-4. doi: 10.1016/j.clnu.2019.12.009. [Epub ahead of print]

PMID:
31874783
4.

Changes in total and segmental bioelectrical resistance are correlated with whole-body and segmental changes in lean soft tissue following a resistance training intervention.

Tinsley GM, Harty PS, Moore ML, Grgic J, Silva AM, Sardinha LB.

J Int Soc Sports Nutr. 2019 Nov 29;16(1):58. doi: 10.1186/s12970-019-0325-4.

5.

Pyriform Costal Cartilage Graft Improves Cleft-Side Alar Asymmetry in Secondary Cleft Rhinoplasty.

Moore MLG, Nguyen TC, Day KM, Weinfeld AB.

Cleft Palate Craniofac J. 2019 Nov 21:1055665619882558. doi: 10.1177/1055665619882558. [Epub ahead of print]

PMID:
31749373
6.

Digital anthropometry via three-dimensional optical scanning: evaluation of four commercially available systems.

Tinsley GM, Moore ML, Dellinger JR, Adamson BT, Benavides ML.

Eur J Clin Nutr. 2019 Nov 4. doi: 10.1038/s41430-019-0526-6. [Epub ahead of print]

PMID:
31685968
7.

Antigenicity and immunogenicity of unique prefusion-mimic F proteins presented on enveloped virus-like particles.

Kwon YM, Lee Y, Kim KH, Jung YJ, Li Z, Jeeva S, Lee S, Moore ML, Kang SM.

Vaccine. 2019 Oct 16;37(44):6656-6664. doi: 10.1016/j.vaccine.2019.09.041. Epub 2019 Sep 18.

PMID:
31542260
8.

Cross-sectional and longitudinal agreement between two multifrequency bioimpedance devices for resistance, reactance, and phase angle values.

Tinsley GM, Moore ML, Silva AM, Sardinha LB.

Eur J Clin Nutr. 2019 Aug 27. doi: 10.1038/s41430-019-0496-8. [Epub ahead of print]

PMID:
31455876
9.

Value-based Healthcare: Can Artificial Intelligence Provide Value in Orthopaedic Surgery?

Jayakumar P, Moore MLG, Bozic KJ.

Clin Orthop Relat Res. 2019 Aug;477(8):1777-1780. doi: 10.1097/CORR.0000000000000873. No abstract available.

PMID:
31335596
10.

Respiratory Syncytial Virus Fusion Protein-encoding DNA Vaccine Is Less Effective in Conferring Protection against Inflammatory Disease than a Virus-like Particle Platform.

Kwon YM, Hwang HS, Lee YT, Kim KH, Lee Y, Kim MC, Lee YN, Quan FS, Moore ML, Kang SM.

Immune Netw. 2019 May 27;19(3):e18. doi: 10.4110/in.2019.19.e18. eCollection 2019 Jun.

11.

Time-restricted feeding plus resistance training in active females: a randomized trial.

Tinsley GM, Moore ML, Graybeal AJ, Paoli A, Kim Y, Gonzales JU, Harry JR, VanDusseldorp TA, Kennedy DN, Cruz MR.

Am J Clin Nutr. 2019 Sep 1;110(3):628-640. doi: 10.1093/ajcn/nqz126.

12.

Team Approach: A Multidisciplinary Approach to the Management of Hip and Knee Osteoarthritis.

Jayakumar P, Moore MLG, Bozic KJ.

JBJS Rev. 2019 Jun;7(6):e10. doi: 10.2106/JBJS.RVW.18.00133. No abstract available.

PMID:
31246861
13.

Evaluation of the role of respiratory syncytial virus surface glycoproteins F and G on viral stability and replication: implications for future vaccine design.

DeFord DM, Nosek JM, Castiglia KR, Hasik EF, Franke ME, Nick BC, Abdelnour AM, Haas CE, Junod NA, Latsko KN, Moore ML, Berthrong ST, Rostad CA, Stobart CC.

J Gen Virol. 2019 Jul;100(7):1112-1122. doi: 10.1099/jgv.0.001287. Epub 2019 Jun 11.

PMID:
31184573
14.

Scalable Biosynthesis of the Seaweed Neurochemical, Kainic Acid.

Chekan JR, McKinnie SMK, Moore ML, Poplawski SG, Michael TP, Moore BS.

Angew Chem Int Ed Engl. 2019 Jun 17;58(25):8454-8457. doi: 10.1002/anie.201902910. Epub 2019 May 10.

PMID:
30995339
15.

Global Contributions to Aesthetic Surgery Journal Over the Past Decade.

Moore MLG, Van Belle C, Ovalle F, Kitzmiller WJ, Gobble RM.

Aesthet Surg J. 2019 Nov 13;39(12):1447-1454. doi: 10.1093/asj/sjz068.

PMID:
30868156
16.

Using urine metabolomics to understand the pathogenesis of infant respiratory syncytial virus (RSV) infection and its role in childhood wheezing.

Turi KN, Romick-Rosendale L, Gebretsadik T, Watanabe M, Brunwasser S, Anderson LJ, Moore ML, Larkin EK, Peebles RS Jr, Hartert TV.

Metabolomics. 2018 Oct 1;14(10):135. doi: 10.1007/s11306-018-1431-z.

17.

Concise Review: Exploring Immunomodulatory Features of Mesenchymal Stromal Cells in Humanized Mouse Models.

Mehler VJ, Burns C, Moore ML.

Stem Cells. 2019 Mar;37(3):298-305. doi: 10.1002/stem.2948. Epub 2018 Dec 21. Review.

18.

Precision of Dual-Energy X-Ray Absorptiometry Reflection Scans in Muscular Athletes.

Tinsley GM, Moore ML, Graybeal AJ.

J Clin Densitom. 2018 Sep 13. pii: S1094-6950(18)30172-0. doi: 10.1016/j.jocd.2018.09.005. [Epub ahead of print]

PMID:
30327241
19.

Resting metabolic rate in muscular physique athletes: validity of existing methods and development of new prediction equations.

Tinsley GM, Graybeal AJ, Moore ML.

Appl Physiol Nutr Metab. 2019 Apr;44(4):397-406. doi: 10.1139/apnm-2018-0412. Epub 2018 Sep 21.

PMID:
30240568
20.

Body Composition Assessment in Male and Female Bodybuilders: A 4-Compartment Model Comparison of Dual-Energy X-Ray Absorptiometry and Impedance-Based Devices.

Graybeal AJ, Moore ML, Cruz MR, Tinsley GM.

J Strength Cond Res. 2018 Aug 29. doi: 10.1519/JSC.0000000000002831. [Epub ahead of print]

PMID:
30161092
21.

The Morphology and Assembly of Respiratory Syncytial Virus Revealed by Cryo-Electron Tomography.

Ke Z, Dillard RS, Chirkova T, Leon F, Stobart CC, Hampton CM, Strauss JD, Rajan D, Rostad CA, Taylor JV, Yi H, Shah R, Jin M, Hartert TV, Peebles RS Jr, Graham BS, Moore ML, Anderson LJ, Wright ER.

Viruses. 2018 Aug 20;10(8). pii: E446. doi: 10.3390/v10080446.

22.

Fat-free Mass Characteristics of Muscular Physique Athletes.

Tinsley GM, Graybeal AJ, Moore ML, Nickerson BS.

Med Sci Sports Exerc. 2019 Jan;51(1):193-201. doi: 10.1249/MSS.0000000000001749.

PMID:
30095745
23.

Orally Efficacious Broad-Spectrum Ribonucleoside Analog Inhibitor of Influenza and Respiratory Syncytial Viruses.

Yoon JJ, Toots M, Lee S, Lee ME, Ludeke B, Luczo JM, Ganti K, Cox RM, Sticher ZM, Edpuganti V, Mitchell DG, Lockwood MA, Kolykhalov AA, Greninger AL, Moore ML, Painter GR, Lowen AC, Tompkins SM, Fearns R, Natchus MG, Plemper RK.

Antimicrob Agents Chemother. 2018 Jul 27;62(8). pii: e00766-18. doi: 10.1128/AAC.00766-18. Print 2018 Aug.

24.

Commentary on "Prognostic effect of carcinoma in situ in muscle-invasive urothelial carcinoma patients receiving neoadjuvant chemotherapy."

Thomas DE, Kaimakliotis HZ, Rice KR, Pereira JA, Johnston P, Moore ML, Reed A, Cregar DM, Franklin C, Loman RL, Koch MO, Bihrle R, Foster RS, Masterson TA, Gardner TA, Sundaram CP, Powell CR, Beck S, Grignon DJ, Cheng L, Albany C, Hahn NM.

Urol Oncol. 2018 Jul;36(7):345. doi: 10.1016/j.urolonc.2018.05.003. Epub 2018 Jun 5.

PMID:
29880459
25.

Infant Viral Respiratory Infection Nasal Immune-Response Patterns and Their Association with Subsequent Childhood Recurrent Wheeze.

Turi KN, Shankar J, Anderson LJ, Rajan D, Gaston K, Gebretsadik T, Das SR, Stone C, Larkin EK, Rosas-Salazar C, Brunwasser SM, Moore ML, Peebles RS Jr, Hartert TV.

Am J Respir Crit Care Med. 2018 Oct 15;198(8):1064-1073. doi: 10.1164/rccm.201711-2348OC.

26.

Glucagon-like peptide 1 receptor signaling attenuates respiratory syncytial virus-induced type 2 responses and immunopathology.

Bloodworth MH, Rusznak M, Pfister CC, Zhang J, Bastarache L, Calvillo SA, Chappell JD, Boyd KL, Toki S, Newcomb DC, Stier MT, Zhou W, Goleniewska K, Moore ML, Hartert TV, Niswender KD, Peebles RS Jr.

J Allergy Clin Immunol. 2018 Aug;142(2):683-687.e12. doi: 10.1016/j.jaci.2018.01.053. Epub 2018 Apr 17. No abstract available.

27.

Polyvalent vaccines: High-maintenance heroes.

Schlingmann B, Castiglia KR, Stobart CC, Moore ML.

PLoS Pathog. 2018 Apr 5;14(4):e1006904. doi: 10.1371/journal.ppat.1006904. eCollection 2018 Apr. Review. No abstract available.

28.

Human antibody recognition of antigenic site IV on Pneumovirus fusion proteins.

Mousa JJ, Binshtein E, Human S, Fong RH, Alvarado G, Doranz BJ, Moore ML, Ohi MD, Crowe JE Jr.

PLoS Pathog. 2018 Feb 22;14(2):e1006837. doi: 10.1371/journal.ppat.1006837. eCollection 2018 Feb.

29.

Improving communication between obstetric and neonatology teams for high-risk deliveries: a quality improvement project.

Sundgren NC, Kelly FC, Weber EM, Moore ML, Gokulakrishnan G, Hagan JL, Brand MC, Gallegos JO, Levy BE, Fortunov RM.

BMJ Open Qual. 2017 Dec 14;6(2):e000095. doi: 10.1136/bmjoq-2017-000095. eCollection 2017.

30.

Reliability of hunger-related assessments during 24-hour fasts and their relationship to body composition and subsequent energy compensation.

Tinsley GM, Moore ML, Graybeal AJ.

Physiol Behav. 2018 May 1;188:221-226. doi: 10.1016/j.physbeh.2018.02.017. Epub 2018 Feb 10.

PMID:
29438660
31.

Nasopharyngeal Lactobacillus is associated with a reduced risk of childhood wheezing illnesses following acute respiratory syncytial virus infection in infancy.

Rosas-Salazar C, Shilts MH, Tovchigrechko A, Schobel S, Chappell JD, Larkin EK, Gebretsadik T, Halpin RA, Nelson KE, Moore ML, Anderson LJ, Peebles RS Jr, Das SR, Hartert TV.

J Allergy Clin Immunol. 2018 Nov;142(5):1447-1456.e9. doi: 10.1016/j.jaci.2017.10.049. Epub 2018 Jan 10.

32.

Enhancing the Thermostability and Immunogenicity of a Respiratory Syncytial Virus (RSV) Live-Attenuated Vaccine by Incorporating Unique RSV Line19F Protein Residues.

Rostad CA, Stobart CC, Todd SO, Molina SA, Lee S, Blanco JCG, Moore ML.

J Virol. 2018 Feb 26;92(6). pii: e01568-17. doi: 10.1128/JVI.01568-17. Print 2018 Mar 15.

33.

Rhinovirus Biology, Antigenic Diversity, and Advancements in the Design of a Human Rhinovirus Vaccine.

Stobart CC, Nosek JM, Moore ML.

Front Microbiol. 2017 Dec 5;8:2412. doi: 10.3389/fmicb.2017.02412. eCollection 2017.

34.

Structural basis of respiratory syncytial virus subtype-dependent neutralization by an antibody targeting the fusion glycoprotein.

Tian D, Battles MB, Moin SM, Chen M, Modjarrad K, Kumar A, Kanekiyo M, Graepel KW, Taher NM, Hotard AL, Moore ML, Zhao M, Zheng ZZ, Xia NS, McLellan JS, Graham BS.

Nat Commun. 2017 Nov 30;8(1):1877. doi: 10.1038/s41467-017-01858-w.

35.

Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses.

Chatterjee S, Luthra P, Esaulova E, Agapov E, Yen BC, Borek DM, Edwards MR, Mittal A, Jordan DS, Ramanan P, Moore ML, Pappu RV, Holtzman MJ, Artyomov MN, Basler CF, Amarasinghe GK, Leung DW.

Nat Microbiol. 2017 Jun 30;2:17101. doi: 10.1038/nmicrobiol.2017.101.

36.

STAT1 Represses Cytokine-Producing Group 2 and Group 3 Innate Lymphoid Cells during Viral Infection.

Stier MT, Goleniewska K, Cephus JY, Newcomb DC, Sherrill TP, Boyd KL, Bloodworth MH, Moore ML, Chen K, Kolls JK, Peebles RS Jr.

J Immunol. 2017 Jul 15;199(2):510-519. doi: 10.4049/jimmunol.1601984. Epub 2017 Jun 2.

37.

BAC-Based Recovery of Recombinant Respiratory Syncytial Virus (RSV).

Stobart CC, Hotard AL, Meng J, Moore ML.

Methods Mol Biol. 2017;1602:111-124. doi: 10.1007/978-1-4939-6964-7_8.

PMID:
28508217
38.

Antibody-Induced Internalization of the Human Respiratory Syncytial Virus Fusion Protein.

Leemans A, De Schryver M, Van der Gucht W, Heykers A, Pintelon I, Hotard AL, Moore ML, Melero JA, McLellan JS, Graham BS, Broadbent L, Power UF, Caljon G, Cos P, Maes L, Delputte P.

J Virol. 2017 Jun 26;91(14). pii: e00184-17. doi: 10.1128/JVI.00184-17. Print 2017 Jul 15.

39.

Interference Between Respiratory Syncytial Virus and Human Rhinovirus Infection in Infancy.

Achten NB, Wu P, Bont L, Blanken MO, Gebretsadik T, Chappell JD, Wang L, Yu C, Larkin EK, Carroll KN, Anderson LJ, Moore ML, Sloan CD, Hartert TV.

J Infect Dis. 2017 Apr 1;215(7):1102-1106. doi: 10.1093/infdis/jix031.

40.

Mutating the CX3C Motif in the G Protein Should Make a Live Respiratory Syncytial Virus Vaccine Safer and More Effective.

Boyoglu-Barnum S, Todd SO, Meng J, Barnum TR, Chirkova T, Haynes LM, Jadhao SJ, Tripp RA, Oomens AG, Moore ML, Anderson LJ.

J Virol. 2017 Apr 28;91(10). pii: e02059-16. doi: 10.1128/JVI.02059-16. Print 2017 May 15.

41.

Virus-like particle vaccines containing F or F and G proteins confer protection against respiratory syncytial virus without pulmonary inflammation in cotton rats.

Hwang HS, Kim KH, Lee Y, Lee YT, Ko EJ, Park S, Lee JS, Lee BC, Kwon YM, Moore ML, Kang SM.

Hum Vaccin Immunother. 2017 May 4;13(5):1031-1039. doi: 10.1080/21645515.2016.1272743. Epub 2017 Jan 27.

42.

Prognostic Effect of Carcinoma In Situ in Muscle-invasive Urothelial Carcinoma Patients Receiving Neoadjuvant Chemotherapy.

Thomas DE, Kaimakliotis HZ, Rice KR, Pereira JA, Johnston P, Moore ML, Reed A, Cregar DM, Franklin C, Loman RL, Koch MO, Bihrle R, Foster RS, Masterson TA, Gardner TA, Sundaram CP, Powell CR, Beck SDW, Grignon DJ, Cheng L, Albany C, Hahn NM.

Clin Genitourin Cancer. 2017 Aug;15(4):479-486. doi: 10.1016/j.clgc.2016.11.009. Epub 2016 Nov 30.

43.

A live RSV vaccine with engineered thermostability is immunogenic in cotton rats despite high attenuation.

Stobart CC, Rostad CA, Ke Z, Dillard RS, Hampton CM, Strauss JD, Yi H, Hotard AL, Meng J, Pickles RJ, Sakamoto K, Lee S, Currier MG, Moin SM, Graham BS, Boukhvalova MS, Gilbert BE, Blanco JC, Piedra PA, Wright ER, Moore ML.

Nat Commun. 2016 Dec 21;7:13916. doi: 10.1038/ncomms13916.

44.

A Phase II Trial of Dovitinib in BCG-Unresponsive Urothelial Carcinoma with FGFR3 Mutations or Overexpression: Hoosier Cancer Research Network Trial HCRN 12-157.

Hahn NM, Bivalacqua TJ, Ross AE, Netto GJ, Baras A, Park JC, Chapman C, Masterson TA, Koch MO, Bihrle R, Foster RS, Gardner TA, Cheng L, Jones DR, McElyea K, Sandusky GE, Breen T, Liu Z, Albany C, Moore ML, Loman RL, Reed A, Turner SA, De Abreu FB, Gallagher T, Tsongalis GJ, Plimack ER, Greenberg RE, Geynisman DM.

Clin Cancer Res. 2017 Jun 15;23(12):3003-3011. doi: 10.1158/1078-0432.CCR-16-2267. Epub 2016 Dec 8.

45.

Differences in the Nasopharyngeal Microbiome During Acute Respiratory Tract Infection With Human Rhinovirus and Respiratory Syncytial Virus in Infancy.

Rosas-Salazar C, Shilts MH, Tovchigrechko A, Schobel S, Chappell JD, Larkin EK, Shankar J, Yooseph S, Nelson KE, Halpin RA, Moore ML, Anderson LJ, Peebles RS Jr, Das SR, Hartert TV.

J Infect Dis. 2016 Dec 15;214(12):1924-1928.

46.

Caring for Your Most Important Patient: You.

Moore ML.

Home Healthc Now. 2016 Nov/Dec;34(10):577. No abstract available.

PMID:
27805940
47.

Respiratory Syncytial Virus-Infected Mesenchymal Stem Cells Regulate Immunity via Interferon Beta and Indoleamine-2,3-Dioxygenase.

Cheung MB, Sampayo-Escobar V, Green R, Moore ML, Mohapatra S, Mohapatra SS.

PLoS One. 2016 Oct 3;11(10):e0163709. doi: 10.1371/journal.pone.0163709. eCollection 2016.

48.

A polyvalent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques.

Lee S, Nguyen MT, Currier MG, Jenkins JB, Strobert EA, Kajon AE, Madan-Lala R, Bochkov YA, Gern JE, Roy K, Lu X, Erdman DD, Spearman P, Moore ML.

Nat Commun. 2016 Sep 22;7:12838. doi: 10.1038/ncomms12838.

49.

Mental engagement during cognitive and psychomotor tasks: Effects of task type, processing demands, and practice.

Pendleton DM, Sakalik ML, Moore ML, Tomporowski PD.

Int J Psychophysiol. 2016 Nov;109:124-131. doi: 10.1016/j.ijpsycho.2016.08.012. Epub 2016 Aug 29.

PMID:
27585951
50.

Fluorescent and Bioluminescent Reporter Myxoviruses.

Rostad CA, Currier MC, Moore ML.

Viruses. 2016 Aug 4;8(8). pii: E214. doi: 10.3390/v8080214. Review.

Supplemental Content

Loading ...
Support Center